homefeedbacksupportlog on 7-Jan-2009 
  Search
 
   
 
  Top 10s
 Molecular Medicine
  Current Top 10
  All Time Top 10
  Most-viewed Top 10
  Hidden Jewels Top 10

  Sections Covered
Antimicrobial Agents
Autoimmunity
Cancer Therapeutics
Cardiovascular Pharmacology
Cardiovascular Physiology/Circulation
Cell Growth & Division
Drug Discovery & Design
Endocrine & Metabolic Pharmacology
Endocrinology
Gastrointestinal Pharmacology
Gastrointestinal Physiology
Genito-Urinary & Reproductive Pharmacology
Immunomodulation
Immunopharmacology & Hematologic Pharmacology
Integrative Physiology
Medical Genetics
Medical Microbiology
Molecular Pharmacology
Muscle & Connective Tissue
Musculoskeletal & Dermatologic Pharmacology
Neural Homeostasis
Neurobiology of Disease & Regeneration
Neuropharmacology & Psychopharmacology
Pharmacogenomics
Pharmacokinetics & Drug Delivery
Physiogenomics
Renal, Fluid & Electrolyte Physiology
Reproductive Physiology
Respiratory physiology
Stem Cells & Regeneration
Toxicology


 HIDDEN JEWELS | Molecular Medicine | calculated on 7 January 2009
 browse faculty | show Hidden Jewels in

to email [Help]


1
Recommended
F1000 Factor 3.0

Confirmation
New Finding
Neural markers of inhibition in human memory retrieval.
Wimber M, Bäuml KH, …, Heinze HJ, Richardson-Klavehn A
J Neurosci 2008 Dec 10 28(50):13419-27 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Terry Davidson
Evaluated 22 Dec 2008
 
2
Must Read
F1000 Factor 6.0

New Finding
Novel Drug Target
Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Krohn R, Raffetseder U, …, Mertens PR, Weber C
Circulation 2007 Oct 16 116(16):1812-20 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | David Harrison with Klaudia Budzyn
Evaluated 20 May 2008
 
3
Exceptional
F1000 Factor 9.0

New Finding
Organic anion transporter OAT1 undergoes constitutive and protein kinase C-regulated trafficking through a dynamin- and clathrin-dependent pathway.
Zhang Q, Hong M, …, Ma J, You G
J Biol Chem 2008 Nov 21 283(47):32570-9 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Lawrence Lash
Evaluated 2 Jan 2009
 
4
Exceptional
F1000 Factor 9.0

Hypothesis
New Finding
Selective reactions of cutaneous and muscle afferent neurons to peripheral nerve transection in rats.
Hu P, McLachlan EM
J Neurosci 2003 Nov 19 23(33):10559-67 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Wilfrid Jänig
Evaluated 6 Jan 2009
 
5
Exceptional
F1000 Factor 9.0

Hypothesis
New Finding
Tech Advance
Global reorganization of replication domains during embryonic stem cell differentiation.
Hiratani I, Ryba T, …, Schübeler D, Gilbert DM
PLoS Biol 2008 Oct 7 6(10):e245 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Joel Huberman
Evaluated 11 Nov 2008
 
6
Recommended
F1000 Factor 3.0

Tech Advance
Automated method for the isolation of collecting ducts.
Miller RL, Zhang P, …, Rohrwasser A, Nelson RD
Am J Physiol Renal Physiol 2006 Jul 291(1):F236-45 [abstract on PubMed] [related articles] [FREE full text]
Selected by | Dominique Eladari
Evaluated 22 Dec 2008
 
7
Exceptional
F1000 Factor 9.0

New Finding
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.
Abdulla S, Oberholzer R, …, Ballou WR, Tanner M
N Engl J Med 2008 Dec 11 359(24):2533-44 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Murali Ramanathan
Evaluated 22 Dec 2008
 
8
Recommended
F1000 Factor 3.0

Confirmation
Hypothesis
New Finding
Reward-potentiating effects of D-1 dopamine receptor agonist and AMPAR GluR1 antagonist in nucleus accumbens shell and their modulation by food restriction.
Carr KD, Cabeza de Vaca S, Sun Y, Chau LS
Psychopharmacology (Berl) 2008 Oct 8 [abstract on PubMed] [related articles] [full text]
Selected by | Kent Berridge
Evaluated 18 Dec 2008
 
9
Recommended
F1000 Factor 3.0

New Finding
Safety, Pharmacokinetics, and Antiretroviral Activity of Multiple Doses of Ibalizumab (formerly TNX-355), an Anti-CD4 Monoclonal Antibody, in HIV-1 Infected Adults.
Jacobson JM, Kuritzkes DR, …, Weinheimer SP, Lewis ST
Antimicrob Agents Chemother 2008 Nov 17 [abstract on PubMed] [related articles] [full text]
Selected by | Jonathan Schapiro
Evaluated 2 Dec 2008
 
10
Recommended
F1000 Factor 3.0

Confirmation
Hypothesis
New Finding
Cytoskeletal-mediated tension modulates the directed self-assembly of microtissues.
Dean DM, Morgan JR
Tissue Eng Part A 2008 Dec 14(12):1989-97 [abstract on PubMed] [related articles] [full text] [order article]
Selected by | Giulio Gabbiani
Evaluated 12 Dec 2008

Hidden Jewels Top 10 lists are generated every day and comprise only papers published in less widely read journals (the grouping of which is the same for all Faculties; therefore, whilst some of these journals may be considered 'high profile' in their immediate Faculty, they are included in the Hidden Jewels lists because they probably will not be so obvious to people outside that specific Faculty). The Hidden Jewels list of papers is ordered by the number of times a paper's evaluation(s) has been viewed over the past 14 days.


© 1999-2009 Biology Reports Ltd unless otherwise stated. < info@f1000.com >   Terms and conditions   Legal info